Health2 hours ago
Agios Pharmaceuticals Shares Plummet 45% After Mixed Trial Results
Shares of Agios Pharmaceuticals experienced a dramatic decline of approximately 45% during premarket trading on Wednesday following the announcement of mixed results from a late-stage trial...